<!-- google_ad_section_start -->Comparison of Insulin Regimens for Type 2<!-- google_ad_section_end -->
Health Forums

Go Back   Health Forums > Diseases and Conditions > Diabetes > alt.support.diabetes

Reply
 
LinkBack Thread Tools Display Modes
  #1  
Old 09-21-2007, 01:20 PM
Alan S
Guest
 
Posts: n/a
Default Comparison of Insulin Regimens for Type 2

Pre-publication from NEJM. Passed on for those type 2's
considering insulin use or those thinking of varying
regimens.

http://content.nejm.org/cgi/content/...5392?query=TOC

"September 21, 2007 (10.1056/NEJMoa075392)

Addition of Biphasic, Prandial, or Basal Insulin to Oral
Therapy in Type 2 Diabetes

ABSTRACT

Background
Adding insulin to oral therapy in type 2 diabetes mellitus
is customary when glycemic control is suboptimal, though
evidence supporting specific insulin regimens is limited.

Methods
In an open-label, controlled, multicenter trial, we
randomly assigned 708 patients with a suboptimal glycated
hemoglobin level (7.0 to 10.0%) who were receiving maximally
tolerated doses of metformin and sulfonylurea to receive
biphasic insulin aspart twice daily, prandial insulin aspart
three times daily, or basal insulin detemir once daily
(twice if required). Outcome measures at 1 year were the
mean glycated hemoglobin level, the proportion of patients
with a glycated hemoglobin level of 6.5% or less, the rate
of hypoglycemia, and weight gain.

Results At 1 year, mean glycated hemoglobin levels were
similar in the biphasic group (7.3%) and the prandial group
(7.2%) (P=0.08) but higher in the basal group (7.6%, P<0.001
for both comparisons). The respective proportions of
patients with a glycated hemoglobin level of 6.5% or less
were 17.0%, 23.9%, and 8.1%; respective mean numbers of
hypoglycemic events per patient per year were 5.7, 12.0, and
2.3; and respective mean weight gains were 4.7 kg, 5.7 kg,
and 1.9 kg. Rates of adverse events were similar among the
three groups.

Conclusions A single analogue-insulin formulation added to
metformin and sulfonylurea resulted in a glycated hemoglobin
level of 6.5% or less in a minority of patients at 1 year.
The addition of biphasic or prandial insulin aspart reduced
levels more than the addition of basal insulin detemir but
were associated with greater risks of hypoglycemia and
weight gain. (Current Controlled Trials number,
ISRCTN51125379 [controlled-trials.com] .)"

Full version at the link address.

Cheers, Alan, T2, Australia.
d&e, metformin 1500mg, ezetrol 10mg
Everything in Moderation - Except Laughter.
--
http://loraldiabetes.blogspot.com
Reply With Quote
  #2  
Old 09-21-2007, 01:20 PM
Alan S
Guest
 
Posts: n/a
Default Re: Comparison of Insulin Regimens for Type 2

On Fri, 21 Sep 2007 19:40:53 +1000, Alan S
<loralgtweightandcarbs@gmail.com> wrote:

>
>Addition of Biphasic, Prandial, or Basal Insulin to Oral
>Therapy in Type 2 Diabetes


A PS.

The editorial from the NEJM on when to add insulin is also
worth reading:

http://content.nejm.org/cgi/content/...8196?query=TOC
Intention to Treat — Initiating Insulin and the 4-T Study


Cheers, Alan, T2, Australia.
d&e, metformin 1500mg, ezetrol 10mg
Everything in Moderation - Except Laughter.
--
http://loraldiabetes.blogspot.com
Reply With Quote
  #3  
Old 09-21-2007, 06:05 PM
BobBlue1988@gmail.com
Guest
 
Posts: n/a
Default Re: Comparison of Insulin Regimens for Type 2

On Sep 21, 4:43 am, Alan S <loralgtweightandca...@gmail.com> wrote:
> On Fri, 21 Sep 2007 19:40:53 +1000, Alan S
>
> <loralgtweightandca...@gmail.com> wrote:
>
> >Addition of Biphasic, Prandial, or Basal Insulin to Oral
> >Therapy in Type 2 Diabetes

>
> A PS.
>
> The editorial from the NEJM on when to add insulin is also
> worth reading:
>
> http://content.nejm.org/cgi/content/...8196?query=TOC
> Intention to Treat - Initiating Insulin and the 4-T Study
>
> Cheers, Alan, T2, Australia.
> d&e, metformin 1500mg, ezetrol 10mg
> Everything in Moderation - Except Laughter.
> --http://loraldiabetes.blogspot.com


bobblue1988@gmail.com
bobblue1988@yahoo.com
southparkcows07@yahoo.com
southparkcows07@gmail.com

Reply With Quote
  #4  
Old 09-22-2007, 09:37 PM
hemyd
Guest
 
Posts: n/a
Default Re: Comparison of Insulin Regimens for Type 2

Alan S" <loralgtweightandcarbs@gmail.com> wrote in message
news:d547f3tikpk96tbv3e1q3uqnnracno26ja@4ax.com...
> Pre-publication from NEJM. Passed on for those type 2's
> considering insulin use or those thinking of varying
> regimens.
>
> http://content.nejm.org/cgi/content/...5392?query=TOC
>
> "September 21, 2007 (10.1056/NEJMoa075392)
>
> Addition of Biphasic, Prandial, or Basal Insulin to Oral
> Therapy in Type 2 Diabetes
>
> ABSTRACT
>
> Background
> Adding insulin to oral therapy in type 2 diabetes mellitus
> is customary when glycemic control is suboptimal, though
> evidence supporting specific insulin regimens is limited.
>
> Methods
> In an open-label, controlled, multicenter trial, we
> randomly assigned 708 patients with a suboptimal glycated
> hemoglobin level (7.0 to 10.0%) who were receiving maximally
> tolerated doses of metformin and sulfonylurea to receive
> biphasic insulin aspart twice daily, prandial insulin aspart
> three times daily, or basal insulin detemir once daily
> (twice if required). Outcome measures at 1 year were the
> mean glycated hemoglobin level, the proportion of patients
> with a glycated hemoglobin level of 6.5% or less, the rate
> of hypoglycemia, and weight gain.
>
> Results At 1 year, mean glycated hemoglobin levels were
> similar in the biphasic group (7.3%) and the prandial group
> (7.2%) (P=0.08) but higher in the basal group (7.6%, P<0.001
> for both comparisons). The respective proportions of
> patients with a glycated hemoglobin level of 6.5% or less
> were 17.0%, 23.9%, and 8.1%; respective mean numbers of
> hypoglycemic events per patient per year were 5.7, 12.0, and
> 2.3; and respective mean weight gains were 4.7 kg, 5.7 kg,
> and 1.9 kg. Rates of adverse events were similar among the
> three groups.
>
> Conclusions A single analogue-insulin formulation added to
> metformin and sulfonylurea resulted in a glycated hemoglobin
> level of 6.5% or less in a minority of patients at 1 year.
> The addition of biphasic or prandial insulin aspart reduced
> levels more than the addition of basal insulin detemir but
> were associated with greater risks of hypoglycemia and
> weight gain. (Current Controlled Trials number,
> ISRCTN51125379 [controlled-trials.com] .)"
>
> Full version at the link address.
>
> Cheers, Alan, T2, Australia.
> d&e, metformin 1500mg, ezetrol 10mg
> Everything in Moderation - Except Laughter.
> --
> http://loraldiabetes.blogspot.com


Alan,

It was largely due to articles such as the above (although written more
simply), and to the preaching of members on this newsgroup and mhd, in
particular Old Al, that convinced me to go searching for an endo who would
put me on insulin. I started on Lantus last November, than added Novorapid a
couple of months later. Taking Lantus once in the evening killed my
typically high fbg. Taking Novorapid before my main meal killed my post
prandial spikes. My HbA1c went from about 6.7% to 5.8% (I need to have one
done again now). I avoided any significant weight gain by maintaining my
intense exercise routine, and by maintaining my diet (low to moderate carb).
I continue to take a reduced dose of Diamicron, and Metformin. By getting to
know about the interaction of various insulin doses with various diets and
exercise, I have generally managed to avoid hypos, except the odd larger one
due to stupidity in "forgetting" about a dose here and there for too long a
time. .

Incidentally, the endo who put me on insulin has now achieved my aims, and
it's back for me for the occasional visit to a local gp, who is far better
at interacting with regarding my diabetes.

Although never having much time to fully digest articles such as the above,
the meaning was clear.

Henry Mydlarz.


Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is Off
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
VAT --> Insulin Resistance --> Tinnitus, Hypertension, Dyslipidemia, CVD, and type-2 diabetes Andrew B. Chung, MD/PhD alt.support.diabetes 0 08-06-2007 05:43 PM
VAT --> Insulin Resistance (Metabolic Syndrome) --> Type-2 Diabetes Andrew B. Chung, MD/PhD alt.support.diabetes 6 07-20-2007 10:33 AM
Advice needed from insulin users (type 1 or 2) Cloudedbrains alt.support.diabetes 6 07-10-2007 10:45 PM
The purpose of exogeneous insulin in the type-2 diabetic. Andrew B. Chung, MD/PhD alt.support.diabetes 11 02-26-2007 10:23 PM
New Type I, sensitive to insulin, please help! kel4han alt.support.diabetes 28 11-08-2006 10:02 PM


All times are GMT. The time now is 01:52 PM.


Powered by vBulletin® Version 3.7.2
Copyright ©2000 - 2008, Jelsoft Enterprises Ltd.
Search Engine Optimization by vBSEO 3.2.0
     
   
 

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41